| Basic / Advanced Search | Major/Minor MeSH Heading | Sources | Marked List | Saved Queries |
|
Search Results | |
| ||
| ||
| ||
|
| ||
| ||
| ||
| 1 | Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2 | ||
| Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S |
833 | ||
| |||
| |||
| 2 | Screening for second primary lung cancer after treatment of laryngeal cancer | ||
| Ritoe SC, Krabbe PF, Jansen MM, Festen J, Joosten FB, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA |
833 | ||
| |||
| |||
| 3 | The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection | ||
| Field JK, Youngson JH |
833 | ||
| |||
| |||
| 4 | [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer] | ||
| Shi D, Huang G, Miao J, Lin X |
833 | ||
| |||
| |||
| 5 | Familial cancer aggregation and the risk of lung cancer | ||
| Wünsch-Filho V, Boffetta P, Colin D, Moncau JE |
833 | ||
| |||
| |||
| 6 | [Relations of tumor suppressor gene p16 and RB to early diagnosis of lung cancer] | ||
| Ye Y, Su C, Wang D, Guo W, Cheng X, Liu S, Liu Y, Liu B, Cao X, Shan X, Wu M |
833 | ||
| |||
| |||
| 7 | Screening for second primary lung cancer after treatment of laryngeal cancer | ||
| Ritoe SC, Krabbe PF, Jansen MM, Festen J, Joosten FB, Kaanders JH, Van Den Hoogen FJ, Verbeek AL, Marres HA |
833 | ||
| |||
| |||
| 8 | [The role of tumor markers in lung cancer management] | ||
| Ariyoshi Y, Kuwabara M |
833 | ||
| |||
| |||
| 9 | [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer] | ||
| Shi D, Huang G, Miao J, Lin X |
833 | ||
| |||
| |||
| 10 | Extraction of ferruginous bodies from lung tissue obtained at surgery and autopsy. Special reference to carcinoma of lung | ||
| Kimizuka G, Hayashi Y |
833 | ||
| |||
| |||
| 11 | Dark tobacco and lung cancer in Cuba | ||
| Joly OG, Lubin JH, Caraballoso M |
833 | ||
| |||
| |||
| 12 | Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis | ||
| Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP |
833 | ||
| |||
| |||
| 13 | [Clinical analysis of surgically resected multiple primary lung cancer] | ||
| Horinouchi H, Yamamoto M, Goto T, Koyama T, Kamiyama I, Yamauchi N, Horiguchi H, Otsuka T, Inoue Y, Iwamaru Y, Abiko T, Sawafuji M, Watanabe M, Kawamura M, Kobayashi K |
833 | ||
| |||
| |||
| 14 | Lung cancer in patients with HIV-infection | ||
| Vyzula R, Remick SC |
833 | ||
| |||
| |||
| 15 | Occupational lung cancer | ||
| Coultas DB, Samet JM |
833 | ||
| |||
| |||
| 16 | Monoclonal antibody that distinguishes small-cell lung cancer from non-small-cell lung cancer | ||
| Watanabe J, Okabe T, Fujisawa M, Takaku F, Hirohashi S, Shimosato Y |
833 | ||
| |||
| |||
| 17 | [Applications of aryl hydrocarbon hydroxylase in diagnosis of lung cancer] | ||
| Chen L, Liu Y |
833 | ||
| |||
| |||
| 18 | [Thrombosis diseases and lung cancer] | ||
| Lu W, Li L, Gao Y |
833 | ||
| |||
| |||
| 19 | Clinical measures, smoking, radon exposure, and risk of lung cancer in uranium miners | ||
| Finkelstein MM |
833 | ||
| |||
| |||
| 20 | DNA adduct level in lung tissue may act as a risk biomarker of lung cancer | ||
| Cheng YW, Chen CY, Lin P, Huang KH, Lin TS, Wu MH, Lee H |
833 | ||
| |||
| |||
| 21 | The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection | ||
| Field JK, Youngson JH |
833 | ||
| |||
| |||
| 22 | Lung cancer: a review | ||
| Cersosimo RJ |
833 | ||
| |||
| |||
| 23 | Lung cancer evolution to preinvasive management | ||
| Mulshine JL, Cuttitta F, Tockman MS, De Luca LM |
833 | ||
| |||
| |||
| 24 | Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance | ||
| Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK |
833 | ||
| |||
| |||
| 25 | Second lung cancers in patients after treatment for an initial lung cancer | ||
| Johnson BE |
833 | ||
| |||
| |||
| Select/Deselect All | |||
| |||
Mail Selected
Print Selected
Save to Disk
Clear Selected